Identification of NOX4 as a New Biomarker in Hepatocellular Carcinoma and Its Effect on Sorafenib Therapy

To improve the survival of patients with hepatocellular carcinoma (HCC), new biomarkers and therapeutic targets are urgently needed. In this study, the GEO and TCGA dataset were used to explore the differential co-expressed genes and their prognostic correlation between HCC and normal samples. The m...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Hui-Zhou, Liu, Qing-Qing, Chang, De-Hua, Li, Shu-Xian, Yang, Long-Tao, Zhou, Peng, Deng, Jiang-Bei, Huang, Chang-Hao, Xiao, Yu-Dong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452076/
https://www.ncbi.nlm.nih.gov/pubmed/37626693
http://dx.doi.org/10.3390/biomedicines11082196

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452076/
https://www.ncbi.nlm.nih.gov/pubmed/37626693
http://dx.doi.org/10.3390/biomedicines11082196

Ejemplares similares